This is a non-core endpoint: only basic statistics are computed.
Fibrosarcoma
C3_FIBROSARCOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
260 |
4. Check minimum number of eventsNone |
260 |
5. Include endpointsNone |
260 |
6. Filter based on genotype QC (FinnGen only) |
245 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Fibrosarcoma
based on the number of shared cases.
Similar with more cases:
- Fibrosarcoma, including Hilmo
- Solid cancers, helper endpoint
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 245 | 116 | 129 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | 52.57 | 52.39 | 52.74 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 260
- Matched controls
- 2600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
58.6
54
*
8832/3-C44.5
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of trunk
+∞
47.4
44
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
11.3
37.9
43
45
JN4BD
NOMESCO Finland
Extensive body CT
8.4
29.8
42
58
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
29.8
28
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
29.8
28
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.2
28.5
72
178
H02AB02
ATC
dexamethasone; systemic
43.1
27.9
34
9
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
287.6
26.2
26
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
25.4
24
*
8811/3-C49.2
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
24.3
23
*
XX3DW
NOMESCO Finland
Time consuming IT work
7.8
23.5
35
51
C49.25
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip fibrosarcoma
+∞
23.3
22
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
22.2
21
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
19.0
18
*
8832/3-C44.7
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of lower limb and hip
+∞
19.0
18
*
A04AA02
ATC
granisetron; systemic, transdermal
204.1
18.8
19
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
17.9
17
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
17.9
17
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
17.9
17
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
17.9
17
*
ZZR00
NOMESCO Finland
Flap of skin
102.1
17.8
19
*
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
8.4
17.7
24
31
WZC00
NOMESCO Finland
Treatment plan or consultation
3.2
17.6
96
397
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.0
17.5
28
44
JN4CD
NOMESCO Finland
Very extensive body CT
23.9
17.2
24
11
C49.15
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder fibrosarcoma
+∞
16.8
16
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
16.8
16
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
16.8
16
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
181.1
16.7
17
*
JN4AD
NOMESCO Finland
Body CT examination
6.1
16.4
30
54
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
15.8
15
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
15.8
15
*
8832/3-C44.6
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of upper limb and shoulder
+∞
15.8
15
*
115
Kela drug reimbursment
Breast cancer
+∞
15.8
15
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
16.4
15.2
24
16
C49.21
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip malignant fibrotic histiocytoma
+∞
14.7
14
*
8830/3-C49.2
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
14.7
14
*
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
14.7
14
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
158.5
14.6
15
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
158.5
14.6
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
14.4
84
355
ZZA00
NOMESCO Finland
Split skin graft
11.9
14.4
26
24
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
11.0
14.4
27
27
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.7
14.0
23
37
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
11.9
13.8
25
23
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
13.7
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
25.8
12.6
17
7
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
12.6
12
*
C49.11
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder malignant fibrotic histiocytoma
+∞
12.6
12
*
8832/3-C44.9
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin, NOS
+∞
12.6
12
*
Z51.5
ICD-10 Finland
Palliative care
9.4
12.3
25
29
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
10.1
12.3
24
26
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
10.9
12.3
23
23
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
68.1
11.7
13
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
68.1
11.7
13
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
11.5
11
*
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
11.5
11
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
125.3
11.5
12
*
L03AA13
ATC
pegfilgrastim; parenteral
125.3
11.5
12
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.3
11.5
24
49
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
14.8
11.1
18
13
A04AA01
ATC
ondansetron; systemic, rectal
9.8
10.7
21
23
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
12.8
10.5
18
15
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
16.9
10.5
16
10
8830/3-C49.1
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
10.5
10
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
10.5
10
*
8830/3-C49.6
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
10.5
10
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
10.5
10
*
8810/3-C49.1
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
10.5
10
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
10.5
10
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
10.1
139
860
WF002
NOMESCO Finland
Radical radiotherapy
41.8
10.0
12
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.3
9.8
26
65
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
103.7
9.5
10
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
9.4
9
*
C49.00
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck without histology
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
C49.35
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thoracic fibrosarcoma
+∞
9.4
9
*
159
Kela drug reimbursment
Pazopanib
+∞
9.4
9
*
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
+∞
9.4
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
HA1AA
NOMESCO Finland
X-ray mammography
8.8
9.2
19
23
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
8.4
9.0
19
24
L02BG04
ATC
letrozole; oral
51.8
8.7
10
*
R4120
NOMESCO Finland
Occupational therapy
3.9
8.5
26
72
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
92.9
8.5
9
*
8811/3-C49.1
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
8.4
8
*
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
8.4
8
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
8810/3-C49.2
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
8.4
8
*
343
Kela drug reimbursment
Pazopanib
+∞
8.4
8
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
6.5
8.0
20
33
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
7.9
44
177
WX402
NOMESCO Finland
General anaesthesia
2.6
7.8
51
223
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
15.6
7.8
12
8
NK6AN
NOMESCO Finland
Total body bone isotope imaging
46.4
7.8
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
7.7
54
244
GD1AD
NOMESCO Finland
Thorax CT examination
4.1
7.7
22
58
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
25.9
7.6
10
*
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
7.5
7.6
17
24
ZZF00
NOMESCO Finland
Graft of adipose tissue
82.3
7.5
8
*
NAR40
NOMESCO Finland
Block excision of soft tissue tumour of spine, unspecified
+∞
7.3
7
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
L01AX03
ATC
temozolomide; systemic
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
L03AA02
ATC
filgrastim; parenteral
+∞
7.3
7
*
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
+∞
7.3
7
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
L02BA01
ATC
tamoxifen; oral
+∞
7.3
7
*
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
+∞
7.3
7
*
C49.1
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder
+∞
7.3
7
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
7.3
7
*
8811/3-C49.5
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of pelvis
+∞
7.3
7
*
C49.28
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip Ewing's sarcoma
+∞
7.3
7
*
B01AB05
ATC
enoxaparin; parenteral
2.1
7.2
87
496
S18
ICPC
Laceration/cut
2.0
7.1
124
809
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
14.3
7.0
11
8
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
17.2
6.8
10
6
HAB40
NOMESCO Finland
Wedge excision of mammary gland
41.2
6.8
8
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
6.8
20
54
WZC30
NOMESCO Finland
Teaching
2.7
6.7
39
160
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
6.7
36
142
Z31.5
ICD-10 Finland
Genetic counselling
6.5
6.6
16
26
L02AE02
ATC
leuprorelin; implant, parenteral
71.5
6.5
7
*
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
71.5
6.5
7
*
N02AA05
ATC
oxycodone; systemic
2.4
6.4
46
210
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
11.4
6.4
11
10
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.4
6.3
23
72
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.3
6.3
14
20
C49.55
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of pelvic fibrosarcoma
+∞
6.3
6
*
17131
ICD-8 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb (including hip)
+∞
6.3
6
*
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
6.3
6
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
+∞
6.3
6
*
C49.90
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue without histology
+∞
6.3
6
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
6.3
6
*
C49.3
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of thorax
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
C49.45
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of abdominal fibrosarcoma
+∞
6.3
6
*
C49.59
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis other or unspecified tumor
+∞
6.3
6
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
8.9
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
30
102
3.19
7.24
4.8
1.5
4.74
2.57
ug/l
0.45
24
76
128
858
1.97
6.66
2.7
2.2
—
—
—
0
0
77
455
1.98
5.59
2.4
1.9
—
—
—
0
0
144
1052
1.83
5.34
10.3
6.1
3.89
4.32
e9/l
1.48
128
914
134
980
1.76
4.76
8.0
3.7
13.14
12.04
umol/l
0.20
128
919
12
23
5.42
4.51
1.2
1.2
—
—
—
0
0
186
1518
1.79
4.30
8.6
5.2
81.18
77.67
u/l
0.56
179
1385
120
877
1.68
4.09
5.9
5.5
1.21
1.21
mmol/l
0.14
114
789
7
8
8.95
3.79
1.1
1.5
12.56
12.76
ug/l
—
7
8
41
229
1.94
3.41
5.8
6.2
0.70
1.53
mmol/l
0.68
33
186
24
110
2.30
3.31
5.0
9.2
24.89
25.07
mmol/l
0.10
24
110
9
21
4.40
3.02
1.0
1.0
—
—
—
0
0
124
965
1.54
2.99
6.4
6.1
1.20
1.21
mmol/l
0.69
109
846
8
20
4.09
2.59
1.4
1.4
27.57
187.24
u/ml
—
8
20
121
976
1.45
2.26
11.4
15.7
1.01
1.33
inr
13.70
28
270
142
1192
1.42
2.08
4.3
4.2
6.56
6.80
mmol/l
0.91
136
1112
26
148
1.84
2.07
2.6
2.0
0.21
0.21
g/l
0.02
26
133
38
247
1.63
1.93
4.5
5.7
105.61
103.86
mmol/l
2.25
38
247
8
29
2.81
1.80
1.5
1.4
—
—
—
0
0
47
327
1.53
1.80
1.9
1.7
—
—
—
0
0
9
36
2.55
1.75
1.4
1.3
—
—
—
0
0
70
533
1.43
1.72
2.6
2.9
0.29
0.50
e6/l
0.82
55
400
21
121
1.80
1.64
1.7
1.6
—
—
—
0
0
47
334
1.50
1.64
2.6
2.6
0.70
1.22
e6/l
1.19
26
190
0
42
0.00
1.54
0.0
1.1
—
16.68
—
0
36
168
1496
1.35
1.49
3.6
4.2
11.74
12.20
mm/h
0.18
151
1371
186
1683
1.37
1.48
19.9
15.3
15.91
15.15
%
0.73
186
1651
20
119
1.74
1.42
7.0
7.7
0.71
0.72
%
0.04
20
119
29
191
1.58
1.42
3.6
3.1
—
—
—
0
0
34
234
1.52
1.38
2.0
1.8
—
—
—
0
0
6
23
2.65
1.37
1.5
1.3
—
—
—
0
0
34
235
1.51
1.36
2.0
1.8
—
—
—
0
0
10
49
2.08
1.23
1.4
1.3
—
—
—
0
0
10
49
2.08
1.23
1.4
1.3
—
—
—
0
0
214
2004
1.38
1.19
16.8
13.3
25.43
24.45
mg/l
0.16
173
1553
8
40
2.03
1.13
1.1
1.2
—
—
—
0
0
19
120
1.63
1.12
7.3
7.7
1.45
1.51
%
0.11
19
120
10
52
1.96
1.07
1.6
1.3
—
—
—
0
0
11
60
1.87
1.04
2.5
3.5
—
—
—
0
0
19
124
1.57
1.00
1.4
1.6
—
—
—
0
0
25
349
0.69
1.00
1.2
1.3
21.30
39.02
iu/ml
—
5
115
41
314
1.36
0.98
2.6
2.9
1.30
2.98
e6/l
0.73
19
171
37
473
0.75
0.88
1.4
1.7
496.97
448.81
pmol/l
0.27
29
386
29
214
1.40
0.87
2.6
2.2
11.04
8.48
umol/l
0.19
23
188
33
426
0.74
0.84
1.9
1.7
1109.20
1230.86
nmol/l
0.31
25
332
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
73
625
1.23
0.77
5.5
2.1
2.35
2.36
mmol/l
0.05
65
526
6
34
1.78
0.77
3.0
3.9
54.17
60.88
%
—
6
34
8
134
0.58
0.75
3.5
1.7
—
—
—
0
0
9
58
1.57
0.70
1.3
1.2
—
—
—
0
0
7
43
1.64
0.67
1.0
1.9
0.70
0.93
nmol/l
—
7
34
5
29
1.74
0.64
1.2
1.3
—
—
—
0
0
5
29
1.74
0.64
1.2
1.1
—
—
—
0
0
121
1106
1.18
0.62
2.6
2.7
—
—
—
0
0
10
64
1.59
0.59
1.1
1.2
—
—
—
0
0
10
64
1.59
0.59
1.1
1.2
—
—
—
0
0
10
149
0.66
0.58
2.2
2.6
—
23.03
—
0
7
184
1928
0.84
0.57
6.3
6.2
39.81
40.56
mmol/mol
0.74
170
1788
6
36
1.68
0.57
1.2
1.6
—
—
—
0
0
79
705
1.17
0.53
3.5
3.7
5.18
33.41
mg/mmol
0.58
53
443
6
39
1.55
0.53
1.2
1.6
—
—
—
0
0
14
100
1.42
0.53
1.1
1.3
75.04
112.96
iu/ml
—
5
40
90
819
1.15
0.47
2.4
2.6
184.16
120.89
ug/l
1.01
81
742
79
712
1.16
0.47
2.9
3.0
—
—
—
0
0
8
116
0.68
0.47
3.4
1.6
—
—
—
0
0
12
86
1.41
0.45
1.1
1.3
—
—
—
0
0
137
1288
1.13
0.44
3.2
3.0
44.18
46.60
u/l
0.20
129
1195
13
172
0.74
0.42
4.2
3.9
100.83
81.73
ng/l
0.43
13
156
20
159
1.28
0.41
3.7
2.4
61.38
62.05
ml/min/173m2
—
8
61
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
69
623
1.15
0.40
2.4
2.2
54.90
63.64
u/l
0.50
63
575
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
79
862
0.88
0.40
2.8
3.8
22.34
44.35
ng/l
3.04
57
623
5
35
1.44
0.39
1.0
1.3
—
—
—
0
0
196
1894
1.14
0.38
17.3
11.7
80.21
77.40
ml/min/173m2
1.16
170
1517
201
2070
0.87
0.37
4.8
5.2
2.75
2.67
mmol/l
0.64
180
1903
221
2154
1.17
0.37
12.1
8.9
27.46
25.53
u/l
0.77
211
2067
5
37
1.36
0.37
1.2
1.1
—
—
—
0
0
103
961
1.12
0.36
3.4
3.9
0.00
0.01
estimate
0.50
24
148
5
79
0.63
0.36
1.0
1.7
—
180.00
—
0
5
6
43
1.40
0.35
1.3
1.7
—
—
—
0
0
39
443
0.86
0.34
3.2
4.1
31.31
438.77
ng/l
2.17
31
361
50
555
0.88
0.32
2.1
2.4
346.29
9984.64
umol/l
3.34
45
485
32
277
1.18
0.32
8.3
6.9
—
—
—
0
0
29
250
1.18
0.31
2.0
2.3
18.46
23.76
%
1.53
24
217
197
2022
0.89
0.29
4.4
4.6
4.65
4.57
mmol/l
0.46
178
1867
9
117
0.76
0.28
1.1
2.9
0.35
0.25
e6/l
—
9
112
11
86
1.29
0.26
1.0
1.0
—
—
—
0
0
228
2240
1.15
0.26
24.8
19.0
40.46
40.22
%
0.26
211
2080
55
506
1.11
0.25
4.6
4.1
0.00
0.00
estimate
-0.00
22
134
31
275
1.14
0.24
5.7
4.8
32.40
32.18
%
0.05
20
181
6
81
0.73
0.24
1.3
1.3
—
—
—
0
0
228
2242
1.14
0.24
25.1
19.0
4.48
4.49
e12/l
0.12
222
2163
197
2014
0.91
0.23
4.6
4.7
5.98
6.05
mmol/l
0.41
178
1827
101
961
1.08
0.23
4.3
5.3
0.00
0.00
estimate
-0.00
22
134
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
13
107
1.23
0.22
3.6
3.1
4.59
4.73
pmol/l
0.25
13
94
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
215.36
—
0
11
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
9.11
—
0
10
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
1.02
—
0
5
16
136
1.19
0.20
1.8
1.6
—
—
—
0
0
102
975
1.08
0.20
3.4
3.8
0.00
0.02
estimate
0.50
21
136
6
50
1.20
0.20
1.2
1.2
—
—
—
0
0
196
1999
0.92
0.19
4.4
4.6
1.40
1.47
mmol/l
1.45
177
1832
82
780
1.07
0.18
4.6
3.8
2.56
2.07
ug/l
0.51
71
686
7
58
1.21
0.18
1.0
1.4
—
—
—
0
0
14
119
1.19
0.18
1.1
1.2
313.14
166.16
u/ml
0.46
14
106
15
173
0.86
0.17
2.7
1.8
326.73
387.12
nmol/l
0.47
15
159
73
694
1.07
0.16
2.3
3.0
1375.35
1573.00
ng/l
0.16
68
594
46
429
1.09
0.16
1.8
1.6
0.97
1.10
mg/l
0.25
36
326
227
2241
1.10
0.16
25.1
19.0
244.18
245.87
e9/l
0.16
221
2173
22
197
1.13
0.16
1.1
1.4
—
—
—
0
0
46
431
1.08
0.15
2.6
2.6
0.58
0.76
ug/l
1.61
32
281
9
81
1.12
0.15
1.3
1.5
—
—
—
0
0
17
152
1.13
0.12
2.5
1.8
—
—
—
0
0
191
1936
0.95
0.11
3.9
4.1
1.42
1.29
mmol/l
1.26
173
1760
38
402
0.94
0.10
1.2
1.3
0.53
1.67
u/ml
—
6
119
79
816
0.95
0.10
2.3
2.3
75.99
79.00
nmol/l
0.45
73
718
6
55
1.09
0.09
6.8
1.2
26.83
32.94
mg/l
—
6
45
6
55
1.09
0.09
6.8
1.2
39.52
48.80
mg/l
—
6
46
52
541
0.95
0.09
1.6
1.6
1.37
1.34
mmol/l
0.11
44
447
77
750
1.04
0.07
3.9
4.1
—
—
—
0
0
154
1521
1.03
0.06
3.4
3.7
14.97
14.96
pmol/l
0.03
139
1371
53
515
1.04
0.05
2.0
2.1
2.96
3.01
mg/l
0.07
46
436
90
889
1.02
0.02
1.9
2.0
105.84
94.17
pmol/l
1.14
53
440
53
521
1.02
0.02
1.3
1.5
24.94
21.21
nmol/l
0.65
48
443
186
1854
1.01
0.00
4.2
4.6
1.87
1.96
mu/l
0.47
169
1686
28
282
0.99
0.00
1.3
1.4
—
—
—
0
0
62
622
1.00
0.00
3.3
3.7
21.63
24.23
%
0.66
32
282
32
324
0.99
0.00
1.3
1.3
1.13
8.50
u/ml
1.79
11
131
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
75
0.93
0.00
1.3
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
51
0.98
-0.00
2.2
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.2
—
20.48
—
0
5
0
8
0.00
-0.00
0.0
1.4
—
25.85
—
0
8
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_FIBROSARCOMA – Fibrosarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).